Normal proteins with regions resembling disease-causing prions are responsible for an inherited disorder that affects the brain, muscle, and bone.
The Scientist
Most Recent
Drosophila insulin-like peptides (dILPs) regulate part of the signaling pathway that helps keep organs growing in proportion during development.
Although fully organized patient-run trials are still few and far between, patients are taking a more active role in clinical research.
Contributors
| March 1, 2013
Meet some of the people featured in the March 2013 issue of The Scientist.
Patients are sidestepping clinical research and using themselves as guinea pigs to test new treatments for fatal diseases. Will they hurt themselves, or science?
During development, communication between organs determines their relative final size.
A new project to map the activity of the human brain could receive more than $3 billion dollars in federal funds in President Obama’s upcoming budget proposal.
The first human trial of a treatment using induced pluripotent stem cells has received conditional approval from an institutional review board in Japan.
Tuberculosis bacteria find shelter from drugs and the body’s defenses in bone marrow stem cells.
Using a SMART card containing your genetic information and medical history, you could one day soon be diagnosed and treated for all kinds of diseases at an ATM-style kiosk.
Follow The Scientist
Advertisement
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
